Published in Cancer Weekly, February 14th, 2006
He conducts the scientific and business analysis of early-stage biomedical investment opportunities for RCT and manages a portfolio of projects and investments for RCT. Souvignier's areas of focus at RCT include oncology, pain, central nervous system disorders, diabetes and metabolic disease.
Souvignier's career has focused on the development and commercialization of novel biomedical therapeutics. Before joining RCT, he was manager of international marketing in the commercial operations department at Guilford Pharmaceuticals (now MGI Pharma) in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.